PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Other magnesium preparations
Presentation Product Chemical substance Chapter Items dispensed
Valupak Magnesium tablets
090501300BBFLA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood 229
Magnesium malate 250mg capsules
090501300AABIBI
Generic compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood 107
FSC Magnesium & B6 tablets
090501300BBAJA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood 2
Magnesium malate 300mg capsules
090501300AABJBJ
Generic compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood 1
Solgar Chelated Magnesium 100mg tablets
090501300BBBHA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood 1
Bio-Magnesium tablets
090501300BBEIA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Magnesium hydroxide 187.5mg tablets
090501300AABKBK
Generic compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Slow-Mag 535mg gastro-resistant tablets
090501300BBFVA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Slow-Mag 535mg/110mg gastro-resistant tablets
090501300BBFUA0
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available
Ultra Magnesium tablets
090501300BBFWBK
Proprietary compound preparation BNF 0905013 Other magnesium preparations Nutrition and Blood No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.